Detalhe da pesquisa
1.
Lisocabtagene maraleucel in follicular lymphoma: the phase 2 TRANSCEND FL study.
Nat Med
; 2024 Jun 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38830991
2.
Systematic Literature Review of Real-World Evidence on Dose Escalation and Treatment Switching in Ulcerative Colitis.
Clinicoecon Outcomes Res
; 15: 125-138, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36855750
3.
A Systematic Review of the Economic and Health-Related Quality of Life Impact of Advanced Therapies Used to Treat Moderate-to-Severe Ulcerative Colitis.
Adv Ther
; 40(5): 2116-2146, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37000363
4.
Endoscopic mucosal healing and histologic remission in ulcerative colitis: a systematic literature review of clinical, quality-of-life and economic outcomes.
Curr Med Res Opin
; 38(9): 1531-1541, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35608153
5.
Comparative Efficacy and Safety of Ozanimod and Dimethyl Fumarate for Relapsing-Remitting Multiple Sclerosis Using Matching-Adjusted Indirect Comparison.
CNS Drugs
; 35(7): 795-804, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33847901
6.
Patient and Neurologist Preferences in the United States for Relapsing-Remitting Multiple Sclerosis Treatments: Findings from a Discrete Choice Experiment.
Patient Prefer Adherence
; 15: 1515-1527, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34267507
7.
Patient and neurologist preferences in the UK for relapsing-remitting multiple sclerosis treatments: findings from a discrete choice experiment.
Curr Med Res Opin
; 37(9): 1589-1598, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34129418
8.
Matching-adjusted indirect treatment comparison of ozanimod versus teriflunomide for relapsing multiple sclerosis.
Mult Scler Relat Disord
; 52: 102972, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-33979770
9.
Pharmacist-provided medication therapy management (MTM) program impacts outcomes for employees with diabetes.
Popul Health Manag
; 17(1): 21-7, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23848476
10.
Improving the economic and humanistic outcomes for diabetic patients: making a case for employer-sponsored medication therapy management.
Clinicoecon Outcomes Res
; 5: 153-9, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23610526